Events & Resources
Events
Register for an upcoming webinar and track which industry events our analysts attend.
Learn More →Topics
See All Topics →Latest Articles
Explore our Research →Amazon Prime dominates, but Walmart+ finds foothold among lower-income shoppers
Article |
Jul 16, 2025
Why is MMM making a comeback?
Article |
Jul 16, 2025
Jewelry emerges as luxury’s bright spot
Article |
Jul 16, 2025
Marketers risk missing AI traffic by ignoring desktop
Article |
Jul 16, 2025
Google, Anthropic, OpenAI, Meta: We’re losing visibility into AI
Article |
Jul 16, 2025
Nonessential spending slumps amid tariff price hikes
Article |
Jul 15, 2025
JIC’s measurement audit shows a sector diversifying beyond Nielsen
Article |
Jul 15, 2025
Marketers rush to unify social, CTV strategies
Article |
Jul 15, 2025
AI summaries in Google’s news feed could undercut publisher traffic—again
Article |
Jul 15, 2025
Critics of UnitedHealth Group get louder as the health insurer attempts to quiet them
Article |
Jul 15, 2025
About
Our Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More →Already have a subscription?Sign In
Access All Charts and Data
Transparently sourced data in visual form, perfect for legitimizing your strategic ideas and thought leadership via internal and external presentations.
Access All Charts and Data
Transparently sourced data in visual form, perfect for legitimizing your strategic ideas and thought leadership via internal and external presentations.
August 17, 2021
Industry Trends that Are Expected to Have the Greatest Impact on the Biopharmaceutical Industry in 2021 According to Pharmaceutical Executives Worldwide, Dec 2020 (% of respondents)
Methodology
Data is from an August 2021 GlobalData report titled "The State of the Biopharmaceutical Industry- 2021" as cited in company blog. 198 pharmaceutical executives worldwide at GlobalData clients and prospects were surveyed during November 17-December 11, 2020. The respondents are from approximately 30 countries in North America (n=89), Europe (n=64), Asia-Pacific (n=25), and other parts of the world (n=20). The majority of the respondents from the North America region were coming from the US. The respondents were C-level executives (13%), VP/SVP/EVPs (20%), directors (31%), managers (23%), and associate/nonmanagerial positions (13%). Respondent mix by company size constitutes less than 500 employees (54%), 500-999 employees (10%), 1,000-4,999 employees (14%), 5,000-9,999 employees (7%), and 10,000+ employees (17%).Chart Title
Industry Trends that Are Expected to Have the Greatest Impact on the Biopharmaceutical Industry in 2021 According to Pharmaceutical Executives Worldwide, Dec 2020 (% of respondents)Publication Date
August 17, 2021